Lipitor is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Parke-davis Div Of Pfizer Inc. The primary component is Atorvastatin Calcium Trihydrate.
Product ID | 0071-0155_0ba214c6-250e-42a0-aea8-5e44aba04882 |
NDC | 0071-0155 |
Product Type | Human Prescription Drug |
Proprietary Name | Lipitor |
Generic Name | Atorvastatin Calcium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1996-12-17 |
Marketing Category | NDA / NDA |
Application Number | NDA020702 |
Labeler Name | Parke-Davis Div of Pfizer Inc |
Substance Name | ATORVASTATIN CALCIUM TRIHYDRATE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1996-12-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020702 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1996-12-17 |
Marketing End Date | 2015-02-28 |
Marketing Category | NDA |
Application Number | NDA020702 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-12-17 |
Marketing Category | NDA |
Application Number | NDA020702 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-12-17 |
Marketing Category | NDA |
Application Number | NDA020702 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1996-12-17 |
Marketing Category | NDA |
Application Number | NDA020702 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1996-12-17 |
Ingredient | Strength |
---|---|
ATORVASTATIN CALCIUM TRIHYDRATE | 10 mg/1 |
SPL SET ID: | c6e131fe-e7df-4876-83f7-9156fc4e8228 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0071-0155 | Lipitor | atorvastatin calcium |
0071-0156 | Lipitor | atorvastatin calcium |
0071-0157 | Lipitor | atorvastatin calcium |
0071-0158 | Lipitor | atorvastatin calcium |
70518-0036 | Lipitor | Lipitor |
21695-255 | Lipitor | Lipitor |
49299-1090 | LIPITOR | LIPITOR |
49299-1091 | LIPITOR | LIPITOR |
49299-1092 | LIPITOR | LIPITOR |
49299-1093 | LIPITOR | LIPITOR |
55289-861 | Lipitor | Lipitor |
55289-870 | Lipitor | Lipitor |
55289-800 | Lipitor | Lipitor |
63629-1446 | Lipitor | Lipitor |
63629-6768 | Lipitor | Lipitor |
63629-1447 | Lipitor | Lipitor |
63629-6776 | Lipitor | Lipitor |
63629-6633 | Lipitor | Lipitor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LIPITOR 76554276 2992918 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 2003-10-27 |
LIPITOR 76338379 2891578 Dead/Cancelled |
PFIZER IRELAND PHARMACEUTICALS 2001-11-15 |
LIPITOR 75100704 2074561 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 1995-11-30 |
LIPITOR 75089215 not registered Dead/Abandoned |
WARNER-LAMBERT COMPANY 1996-04-16 |